Division of Urology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada.
Department of Radiation Oncology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada.
Br J Cancer. 2018 May;118(10):1399-1405. doi: 10.1038/s41416-018-0071-4. Epub 2018 Mar 29.
Consultation with radiation oncologists, in addition to urologists, is advocated for patients diagnosed with prostate cancer. Treatment patterns for patients receiving consultation from radiation oncologists in addition to urologists have not previously been described.
We conducted a matched cohort study of men with newly diagnosed non-metastatic prostate cancer in Ontario, Canada. Patients who underwent consultation with a radiation oncologist prior to treatment were matched 1:1 with patients managed by a urologist alone based on tumour and patient characteristics. We examined rates of active treatment (surgery or radiotherapy) within one year following diagnosis.
Among 5708 matched pairs (11,416 patients), those who received radiation oncology consultation were more likely to undergo active treatments whether they had intermediate or high-risk disease (88.6% vs. 65.9%, p < 0.0001; adjusted odds ratio 4.0, 95% CI: 3.6-4.4) or low-risk disease (56.1% vs. 13.3%, p < 0.0001; adjusted odds ratio 8.4, 95% CI: 6.7-10.6). This effect persisted after considering age, comorbidity, tumour volume and year of diagnosis.
Patients newly diagnosed with prostate cancer who receive radiation oncology consultation are associated with a higher rate of active treatment, compared to patients managed by urologists only. Selection and referral biases, and unmeasured confounding such as patient preference must be considered as important factors attributing this association.
除泌尿科医生外,还提倡咨询放射肿瘤学家为前列腺癌患者提供咨询。以前没有描述过接受放射肿瘤学家咨询的患者的治疗模式。
我们在加拿大安大略省对新诊断为非转移性前列腺癌的男性进行了一项匹配队列研究。在治疗前接受放射肿瘤学家咨询的患者根据肿瘤和患者特征与单独由泌尿科医生管理的患者进行 1:1 匹配。我们检查了诊断后一年内接受积极治疗(手术或放射治疗)的比例。
在 5708 对匹配的患者(11416 例患者)中,无论患有中危或高危疾病(88.6%比 65.9%,p<0.0001;调整后的优势比为 4.0,95%置信区间:3.6-4.4)还是低危疾病(56.1%比 13.3%,p<0.0001;调整后的优势比为 8.4,95%置信区间:6.7-10.6),接受放射肿瘤学咨询的患者更有可能接受积极治疗。这种影响在考虑年龄、合并症、肿瘤体积和诊断年份后仍然存在。
与仅由泌尿科医生管理的患者相比,新诊断为前列腺癌的患者接受放射肿瘤学咨询与更高的积极治疗率相关。选择和转诊偏见以及未测量的混杂因素(如患者偏好)必须被视为导致这种关联的重要因素。